Identification of a MHC class-II restricted epitope in carcinoembryonic antigen

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2004-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-003-0455-yPMID 14624313PMCID PMC11034193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NKT Cells Provide Help for Dendritic Cell-Dependent Priming of MHC Class I-Restricted CD8+ T Cells In Vivo 1

  2003cited by this paper
• Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection

  2002cited by this paper
• Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides1

  2002cited by this paper
• Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma

  2002cited by this paper
• Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.

  2002cited by this paper
• Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell.

  2002cited by this paper
• Progress in human tumour immunology and immunotherapy

  2001cited by this paper
• Acetylcholine Receptor Peptide Recognition in HLA DR3-Transgenic Mice: In Vivo Responses Correlate with MHC-Peptide Binding1

  2001cited by this paper
• Identification of T helper epitopes from prostatic acid phosphatase.

  2001cited by this paper
• CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production

  2001cited by this paper
• Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein.

  2001cited by this paper
• Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

  2001cited by this paper
• Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells.

  2000cited by this paper
• Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma

  2000cited by this paper
• the Identification of Tumor-reactive T-Cell Epitopes Use of Two Predictive Algorithms of the World Wide Web for Updated

  2000cited by this paper
• In Vitro and In Vivo Induction of a Th Cell Response Toward Peptides of the Melanoma-Associated Glycoprotein 100 Protein Selected by the TEPITOPE Program1

  2000cited by this paper
• Identification of a MHC Class II-Restricted Human gp100 Epitope Using DR4-IE Transgenic Mice

  2000cited by this paper
• Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells.

  2000cited by this paper
• Detection of T Helper Responses, But Not of Human Papillomavirus-Specific Cytotoxic T Lymphocyte Responses, After Peptide Vaccination of Patients With Cervical Carcinoma

  2000cited by this paper
• MHC-Binding Peptides as Immunotherapeutics for Cancer

  2000cited by this paper
• Melan-A/MART-151–73 represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4+ T cells

  2000cited by this paper
• CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ

  1999cited by this paper
• HLA class II transgenic mice: models of the human CD4+ T‐cell immune response

  1999cited by this paper
• Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.

  1999cited by this paper
• Inducing autoimmune disease to treat cancer.

  1999cited by this paper
• CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.

  1999cited by this paper
• Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11

  1999cited by this paper
• Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes

  1999cited by this paper
• The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.

  1999cited by this paper
• Identification of HLA‐A24 epitope peptides of carcinoembryonic antigen which induce tumor‐reactive cytotoxic T lymphocyte

  1999influential reference
• A new era for cancer immunotherapy based on the genes that encode cancer antigens.

  1999cited by this paper
• A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma.

  1999cited by this paper
• The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses

  1998cited by this paper
• Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors.

  1998influential reference
• Role of carcinoembryonic antigen in the management of advanced colorectal cancer.

  1998cited by this paper
• T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin.

  1998influential reference
• Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice.

  1998cited by this paper
• Identification of autoantigen epitopes in MHC Class II transgenic mice

  1998cited by this paper
• Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors.

  1998cited by this paper
• HLA-DR/DQ Transgenic, class II deficient mice as a novel model to select for HSP T cell epitopes with immunotherapeutic or preventative vaccine potential

  1998cited by this paper
• Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

  1998cited by this paper
• The role of CD4+ T cell responses in antitumor immunity.

  1998influential reference
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

  1998cited by this paper
• HLA class II peptide binding specificity and autoimmunity.

  1997cited by this paper
• Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.

  1997cited by this paper
• Identification of potential HLA-A *0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA).

  1997cited by this paper
• Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions

  1997cited by this paper
• Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help

  1997cited by this paper
• Carcinoembryonic antigen as a target for cancer vaccines

  1996cited by this paper
• Granulocyte‐macrophage‐colony‐stimulating factor enhances immune responses to melanoma‐associated peptides in vivo

  1996cited by this paper
• Generation of cytotoxic T‐cell responses with synthetic melanoma‐associated peptides in vivo: Implications for tumor vaccines with melanoma‐associated antigens

  1996cited by this paper
• Functional diversity of helper T lymphocytes

  1996cited by this paper
• Induction of antitumor immunity using bone marrow-generated dendritic cells.

  1996cited by this paper
• Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

  1995cited by this paper
• Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3

  1995cited by this paper
• Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.

  1995cited by this paper
• Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

  1994cited by this paper
• Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

  1994cited by this paper
• Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.

  1994cited by this paper
• Structure of peptides associated with class I and class II MHC molecules.

  1994cited by this paper
• Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives

  1991cited by this paper
• The effect of class II gene transfection on the tumourigenicity of the H-2K-negative mouse leukaemia cell line K36.16.

  1991cited by this paper
• Carcinoembryonic antigen family: characterization of cDNAs coding for NCA and CEA and suggestion of nonrandom sequence variation in their conserved loop-domains.

  1988cited by this paper
• CEA-related antigens: molecular biology and clinical significance.

  1985cited by this paper
• The human secondary immune response to Keyhole limpet haemocyanin.

  1972cited by this paper

• Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine

  2015cites this paper
• A focused immune response targeting the homotypic binding domain of the carcinoembryonic antigen blocks the establishment of tumor foci in vivo

  2012cites this paper
• Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens.

  2012cites this paper
• Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer

  2011cites this paper
• Screening of Human Tumor Antigens for CD4+ T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries

  2010cites this paper
• HLA Class II Antigen Presentation in Prostate Cancer Cells: A Novel Approach to Prostate Tumor Immunotherapy.

  2010cites this paper
• Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3.

  2009cites this paper
• Identifying tumor antigens in endocrine malignancies.

  2009cites this paper
• In silico methods for predicting T-cell epitopes: Dr Jekyll or Mr Hyde?

  2009cites this paper
• Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen

  2009cites this paper
• in Pancreatic Carcinoma Patients T Cell Immunity Is Impaired + Antiviral CD4 Carcinoembryonic Antigen-Specific but Not

  2008cites this paper
• Carcinoembryonic Antigen-Specific but Not Antiviral CD4+ T Cell Immunity Is Impaired in Pancreatic Carcinoma Patients1

  2008cites this paper
• , Ping Respiratory Syndrome Coronavirus Nucleocapsid Protein of Severe Acute Dominant Helper T-Cell Epitopes in the Identification and Characterization of

  2007cites this paper
• Different Forms of Helper Tolerance to Carcinoembryonic Antigen: Ignorance and Regulation

  2007cites this paper
• Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers.

  2006cites this paper
• Identification of Novel Subdominant Epitopes on the Carcinoembryonic Antigen Recognized by CD4+ T Cells of Lung Cancer Patients1

  2006cites this paper
• T Cells of Lung Cancer Patients + by CD4 Recognized on the Carcinoembryonic Antigen Identification of Novel Subdominant Epitopes

  2006cites this paper
• Recent advances in tumour antigen‐specific therapy: In vivo veritas

  2005cites this paper
• Analyses of Recombinant Vaccinia and Fowlpox Vaccine Vectors Expressing Transgenes for Two Human Tumor Antigens and Three Human Costimulatory Molecules

  2005cites this paper
• CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors

  2005cites this paper
• In Silico Prediction of Peptides Binding to Multiple HLA-DR Molecules Accurately Identifies Immunodominant Epitopes from gp43 of Paracoccidioides brasiliensis Frequently Recognized in Primary Peripheral Blood Mononuclear Cell Responses from Sensitized Individuals

  2003cites this paper